138 related articles for article (PubMed ID: 3338370)
21. Protective effect of the PAF-antagonist BN 52021 on several models of gastro-intestinal mucosal damage in rats.
Etienne A; Thonier F; Braquet P
Int J Tissue React; 1989; 11(2):59-64. PubMed ID: 2693389
[TBL] [Abstract][Full Text] [Related]
22. Intravenous injections of PAF-acether induce platelet aggregation in rats.
Martins MA; Martins PM; Faria Neto HC; Bozza PT; Dias PM; Cordeiro RS; Vargaftig BB
Eur J Pharmacol; 1988 Apr; 149(1-2):89-96. PubMed ID: 3135199
[TBL] [Abstract][Full Text] [Related]
23. Involvement of PAF-acether in the anaphylactic shock in the rat.
Damas J
J Lipid Mediat; 1989; 1(3):161-70. PubMed ID: 2519891
[TBL] [Abstract][Full Text] [Related]
24. Microvascular actions of platelet-activating factor on rat gastric mucosa and submucosa.
Whittle BJ; Morishita T; Ohya Y; Leung FW; Guth PH
Am J Physiol; 1986 Dec; 251(6 Pt 1):G772-8. PubMed ID: 3789144
[TBL] [Abstract][Full Text] [Related]
25. PF-5901 inhibits gastrointestinal platelet-activating factor synthesis in vivo.
Hogaboam CM; Donigi-Gale D; Shoupe TS; Wallace JL
Eur J Pharmacol; 1992 Jun; 216(2):315-8. PubMed ID: 1397016
[TBL] [Abstract][Full Text] [Related]
26. Increase in the rat blood leukocyte counts induced by PAF-acether is suppressed by general anesthesia.
Bozza PT; Silva PM; Castro-Faria-Neto HC; Martins MA; Cordeiro RS
J Leukoc Biol; 1992 Feb; 51(2):146-50. PubMed ID: 1431550
[TBL] [Abstract][Full Text] [Related]
27. Assessment of the role of platelet-activating factor in an animal model of inflammatory bowel disease.
Wallace JL; Braquet P; Ibbotson GC; MacNaughton WK; Cirino G
J Lipid Mediat; 1989; 1(1):13-23. PubMed ID: 2519884
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of rat endotoxin-induced lethality by BN 52021 and BN 52063, compounds with PAF-acether antagonistic effect and protease-inhibitory activity.
Etienne A; Hecquet F; Guilmard C; Soulard C; Braquet P
Int J Tissue React; 1987; 9(1):19-26. PubMed ID: 3596954
[TBL] [Abstract][Full Text] [Related]
29. Platelet-activating factor-induced ischemic bowel necrosis: the effect of platelet-activating factor acetylhydrolase.
Furukawa M; Lee EL; Johnston JM
Pediatr Res; 1993 Aug; 34(2):237-41. PubMed ID: 8233731
[TBL] [Abstract][Full Text] [Related]
30. Role of neutrophils in gastric damage induced by platelet activating factor.
Etienne A; Thonier F; Hecquet F; Braquet P
Naunyn Schmiedebergs Arch Pharmacol; 1988 Oct; 338(4):422-5. PubMed ID: 3244384
[TBL] [Abstract][Full Text] [Related]
31. Effect of senna is not mediated by platelet-activating factor.
Capasso F; Izzo AA; Mascolo N; Autore G; Di Carlo G
Pharmacology; 1993 Oct; 47 Suppl 1():58-63. PubMed ID: 8234442
[TBL] [Abstract][Full Text] [Related]
32. Interactions of constitutive nitric oxide with PAF and thromboxane on rat intestinal vascular integrity in acute endotoxaemia.
László F; Whittle BJ; Moncada S
Br J Pharmacol; 1994 Dec; 113(4):1131-6. PubMed ID: 7889265
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological modulation of Paf-induced rat pleurisy and its role in inflammation by zymosan.
Martins MA; Silva PM; Faria Neto HC; Bozza PT; Dias PM; Lima MC; Cordeiro RS; Vargaftig BB
Br J Pharmacol; 1989 Feb; 96(2):363-71. PubMed ID: 2924083
[TBL] [Abstract][Full Text] [Related]
34. Decrease in IgE Fc receptor expression on mouse bone marrow-derived mast cells and inhibition of paf-acether formation and of beta-hexosaminidase release by dexamethasone.
Benhamou M; Ninio E; Salem P; Hieblot C; Bessou G; Pitton C; Liu FT; Mencia-Huerta JM
J Immunol; 1986 Feb; 136(4):1385-92. PubMed ID: 2935578
[TBL] [Abstract][Full Text] [Related]
35. Failure of prostaglandin E2 and its 16,16-dimethyl analogue to prevent the gastric mucosal damage induced by Paf.
Steel G; Wallace JL; Whittle BJ
Br J Pharmacol; 1987 Feb; 90(2):365-71. PubMed ID: 3470106
[TBL] [Abstract][Full Text] [Related]
36. PAF formation by human gastrointestinal mucosa/submucosa in-vitro: release by ricinoleic acid, and inhibition by 5-aminosalicylic acid.
Capasso F; Tavares IA; Bennett A
J Pharm Pharmacol; 1992 Sep; 44(9):771-2. PubMed ID: 1360533
[TBL] [Abstract][Full Text] [Related]
37. The platelet-independent release of thromboxane A2 by Paf-acether from guinea-pig lungs involves mechanisms distinct from those for leukotriene.
Lefort J; Rotilio D; Vargaftig BB
Br J Pharmacol; 1984 Jul; 82(3):565-75. PubMed ID: 6430375
[TBL] [Abstract][Full Text] [Related]
38. Effect of platelet-activating factor and its receptor antagonist, SRI 63-675, on gastric bleeding in rats.
Berstad A; Almodovar K; Weatherstone RG; Hirschowitz BI
Scand J Gastroenterol; 1988 Aug; 23(6):738-42. PubMed ID: 3262915
[TBL] [Abstract][Full Text] [Related]
39. Platelet-activating factor mediates gastric damage induced by hemorrhagic shock.
Wallace JL; Hogaboam CM; McKnight GW
Am J Physiol; 1990 Jul; 259(1 Pt 1):G140-6. PubMed ID: 2372058
[TBL] [Abstract][Full Text] [Related]
40. Effect of platelet-activating factor on hypothalamic and hypophyseal pro-opiomelanocortin-related peptides and hypothalamo-pituitary-adrenal axis in the rat.
Blasquez C; Jégou S; Delarue C; Delbende C; Bunel DT; Braquet P; Vaudry H
Eur J Pharmacol; 1990 Feb; 177(3):145-53. PubMed ID: 2155805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]